ABVC BioPharma, Inc. Financing Receivable, Accrued Interest, after Allowance for Credit Loss
ABVC BioPharma, Inc. (ABVC) had Financing Receivable, Accrued Interest, after Allowance for Credit Loss of $81.40 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss · last filed 2022-11-14
- 2022-09-30: Financing Receivable, Accrued Interest, after Allowance for Credit Loss $81.40K.
- 2021-12-31: Financing Receivable, Accrued Interest, after Allowance for Credit Loss $2.33K.
| Period end | Financing Receivable, Accrued Interest, after Allowance for Credit Loss |
|---|---|
| 2022-09-30 | $81.40K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $2.33K 10-Q · filed 2022-11-14 |